Landos Biopharma LABP
$ 22.93
0.58%
Annual report 2023
added 03-21-2024
Country |
USA |
IPO year |
2021 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Josep Bassaganya-Riera DVM, Ph.D. |
Employees in the company |
33 |
Shares |
6.28 M |
Market Cap[1] |
$ 144 M |
EBITDA (LTM) |
$ -45.8 M |
P/E (LTM) |
-1.05 |
P/S (LTM) |
- |
EPS (LTM) |
-3.62 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.